Technical Analysis for ADMA - ADMA Biologics Inc

Grade Last Price % Change Price Change
B 21.37 3.59% 0.74
ADMA closed up 3.59 percent on Wednesday, November 20, 2024, on 41 percent of normal volume.
5 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Multiple of Ten Bullish Other 3.59%
Wide Bands Range Expansion 3.59%
NR7 Range Contraction 9.37%
Wide Bands Range Expansion 9.37%
Multiple of Ten Bearish Other 12.24%
Wide Bands Range Expansion 12.24%
Down 3 Days in a Row Weakness 12.24%
Down 4 Days in a Row Weakness 12.24%

   Recent Intraday Alerts

Alert Time
Up 3% about 18 hours ago
60 Minute Opening Range Breakout about 21 hours ago
Rose Above 10 DMA about 21 hours ago
Up 2% about 21 hours ago
Up 1% about 21 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. RI-002 is an injectable immune globulin derived from human plasma enriched with high levels of naturally occurring polyclonal antibodies, as well as high levels of antibodies targeted to respiratory syncytial virus. The company also operates ADMA BioCenters, which are plasma collection centers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Biology Immunology Immune System Infectious Diseases Antibodies IBD 50 Antibody Glycoproteins Polyclonal Antibodies

Is ADMA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 23.64
52 Week Low 3.6
Average Volume 5,516,560
200-Day Moving Average 12.09
50-Day Moving Average 18.72
20-Day Moving Average 19.20
10-Day Moving Average 20.89
Average True Range 1.13
RSI (14) 60.94
ADX 32.26
+DI 38.69
-DI 21.46
Chandelier Exit (Long, 3 ATRs) 20.24
Chandelier Exit (Short, 3 ATRs) 18.74
Upper Bollinger Bands 23.49
Lower Bollinger Band 14.91
Percent B (%b) 0.75
BandWidth 44.69
MACD Line 0.84
MACD Signal Line 0.74
MACD Histogram 0.0963
Fundamentals Value
Market Cap 4.83 Billion
Num Shares 226 Million
EPS -0.11
Price-to-Earnings (P/E) Ratio -194.27
Price-to-Sales 5.05
Price-to-Book 7.81
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.76
Resistance 3 (R3) 22.61 22.00 22.53
Resistance 2 (R2) 22.00 21.65 22.08 22.45
Resistance 1 (R1) 21.69 21.43 21.85 21.83 22.37
Pivot Point 21.08 21.08 21.16 21.15 21.08
Support 1 (S1) 20.76 20.72 20.92 20.91 20.37
Support 2 (S2) 20.15 20.51 20.23 20.29
Support 3 (S3) 19.84 20.15 20.21
Support 4 (S4) 19.98